Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Crit Rev Oncol Hematol. 2017 Sep 8;120:217–226. doi: 10.1016/j.critrevonc.2017.09.003

Figure 2.

Figure 2

Schematic diagram detailing the pathogenesis of cancer induced bone loss. PTHrP: Parathyroid Hormone related Peptide, PTH: Parathyroid hormone, IL-6: interleukin 6, IL-3: interleukin 3, RANKL: Receptor activator of nuclear factor B ligand.